SCHEMBL24539770

SCHEMBL24539770

CC1(C)OB(c2cccc3c4ccc5oc6ccccc6c5c4c4ccccc4c23)OC1(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC14B O60729 1/20 0.35
CDC14A Q9UNH5 1/20 0.35
LPL P06858 3/20 0.34
LIPG Q9Y5X9 3/20 0.34
MAOA P21397 5/20 0.33
MAPT P10636 4/20 0.33
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33
PGAM1 P18669 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
JAK2 O60674 1/20 0.32
BTK Q06187 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21331592 0.97 CDC14B (0.33) CDC14BCDC14ALPLLIPGMAOA
SCHEMBL31759037 0.97 CDC14B (0.33) CDC14BCDC14ALPLLIPGMAOA
SCHEMBL20465344 0.90 CDC14B (0.35) CDC14BCDC14ALPLLIPGMAOA
SCHEMBL30154380 0.90 CDC14B (0.39) CDC14BCDC14ALPLLIPGMAOA
SCHEMBL17242061 0.90 CDC14B (0.39) CDC14BCDC14ALPLLIPGMAOA
SCHEMBL25505534 0.87 LPL (0.38) CDC14BCDC14ALPLLIPGMAOA
SCHEMBL21204237 0.86 MEN1 (0.36) CDC14BCDC14ALPLLIPGMAOA
SCHEMBL24627951 0.85 LPL (0.36) CDC14BCDC14ALPLLIPGMAOA
SCHEMBL20465329 0.84 MEN1 (0.39) CDC14BCDC14ALPLLIPGMAOA
SCHEMBL20961077 0.84 LPL (0.36) LPLLIPGMAOAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023432-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2024-01-18 US disclosed
US-20240023432-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2024-01-18 US disclosed
WO-2022131546-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER 엘티소재주식회사 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023432-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER CYP1B1, NOTUM, CYP4F11 CDC14B 3680/4885CDC14A 3720/4885LPL 1765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.